Form 4: Quest Diagnostics CFO Acquires Shares via DRIP

Quest Diagnostics' Executive Vice President and CFO, Sam Samad, acquired 68 shares of common stock through a dividend reinvestment plan.

Summary

• Sam Samad, Executive Vice President & CFO of Quest Diagnostics Inc. (DGX), acquired 68 shares of common stock.
• The transaction occurred on October 21, 2025, at a price of $189.081 per share.
• These shares were acquired pursuant to a dividend reinvestment plan (DRIP) and represent an award of restricted share units.
• Following this transaction, Sam Samad beneficially owns 25,741 shares of Quest Diagnostics common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading arrangement.

Sentiment

Score: 7

Explanation: The acquisition of shares by a key executive, even through a routine dividend reinvestment plan and restricted share unit award, generally indicates continued alignment of management's interests with shareholders and confidence in the company's long-term prospects.

Positives

• An executive acquiring shares, even through a routine dividend reinvestment plan and restricted share unit award, can signal continued confidence in the company's future prospects.
• The transaction was part of a pre-arranged Rule 10b5-1(c) plan, indicating a structured and compliant approach to equity management.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance.

Industry Context

This is a routine insider transaction report for an executive at a major healthcare diagnostics company. It reflects ongoing executive compensation and investment activities rather than broader industry trends.

Comparison to Industry Standards

• This Form 4 reports a standard insider transaction, common across publicly traded companies where executives receive equity compensation or participate in dividend reinvestment plans. The acquisition of shares through a DRIP and as restricted share units is a typical component of executive compensation packages in the healthcare sector and beyond.

Related Party Transactions

• The acquisition of common stock by an Executive Vice President & CFO from the issuer constitutes a related party transaction, as is typical for insider share ownership disclosures.

Stakeholder Impact

• Shareholders may view the insider acquisition as a positive signal of management's continued confidence in the company's performance and future value.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of shares by a key executive through a dividend reinvestment plan and restricted share unit award. While it signals management's continued alignment and confidence, the transaction size is small and does not provide new fundamental information to warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining existing positions based on broader company fundamentals.

Keywords

Quest Diagnostics, DGX, Sam Samad, Form 4, Insider Trading, Share Acquisition, CFO, Restricted Share Units, Dividend Reinvestment Plan, Rule 10b5-1